Previously, we observed that
luteolin effectively inhibited cell growth and induced apoptosis in HL-60 cells. In that study, we also explored the modulatory effects and molecular mechanisms of
pyrrolidine dithiocarbamate (
PDTC) on the cytotoxicity of
luteolin to HL-60 cells. In this study, we found that
PDTC was able to inhibit
luteolin-induced cell apoptosis in a dose-dependent manner. When HL-60 cells were treated with
PDTC for 0.5 h before 60 microM
luteolin treatment, the
DNA ladder disappeared. Moreover, flow cytometry showed that
PDTC had dose dependently decreased the percentage of apoptotic HL-60 cells and had not interfered with
luteolin's ability to change the mitochondrial membrane potential or its ability to trigger the release of
cytochrome c to cytosol. Detection by Western blotting, however, did show that
PDTC had interfered with
luteolin's ability to cleave
poly(ADP-ribose)polymerase and DNA fragmentation of factor-45. Three hours after the
PDTC-pretreated HL-60 cells were treated with 60 microM
luteolin, the product cleaved from Akt started to appear. Therefore, not only was
PDTC able to stop the apoptosis of HL-60 cells treated with
luteolin, it was also found to increase phosphorylation of Akt and
caspase-9. These results suggest that in the
luteolin-induced apoptotic pathway, phosphorylation of
procaspase-9 by survival signals might play an important role in the ultimate fate of HL-60 cells.